As alternative funding pathways decrease and fewer research grants are administered, the relationship between biotech and academia must shift in order to continue to achieve innovation and development. In this podcast, featuring a panel discussion from the 2026 Chief Medical Officer Summit 360°, CMOs and academics present on these shifts in the global clinical development ecosystem, and how academia and biotech can better partner to develop new therapies for patients, with specific examples.
To learn more about the Chief Medical Officer Summit 360°, please visit CMOSummit360.com.
Podden och tillhörande omslagsbild på den här sidan tillhör
Conference Forum. Innehållet i podden är skapat av Conference Forum och inte av,
eller tillsammans med, Poddtoppen.
